Cargando…
LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway
Prostate cancer (PCa) is the most commonly diagnosed malignancy in male. Numerous studies have focused on the molecular mechanisms of carcinogenesis and progression, aiming at developing new therapeutic strategies. Here we describe Lanthionine synthase C-like protein 1 (LanCL1), a member of the LanC...
Autores principales: | Wang, Jianqing, Xiao, Qianyi, Chen, Xu, Tong, Shijun, Sun, Jianliang, Lv, Ruitu, Wang, Siqing, Gou, Yuancheng, Tan, Li, Xu, Jianfeng, Fan, Caibin, Ding, Guanxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833716/ https://www.ncbi.nlm.nih.gov/pubmed/29416001 http://dx.doi.org/10.1038/s41419-017-0207-0 |
Ejemplares similares
-
LanCL proteins are not Involved in Lanthionine Synthesis in Mammals
por: He, Chang, et al.
Publicado: (2017) -
Identification of Critical Pathways and Hub Genes in LanCL1-Overexpressed Prostate Cancer Cells
por: Tang, Run, et al.
Publicado: (2020) -
Single-Cell RNAseq Resolve the Potential Effects of LanCL1 Gene in the Mouse Testis
por: Lu, Jiangting, et al.
Publicado: (2022) -
Lanthionine synthetase C–like protein 2 (LanCL2) is a novel regulator of Akt
por: Zeng, Min, et al.
Publicado: (2014) -
LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice
por: Tan, Honglin, et al.
Publicado: (2019)